A detailed history of Canada Pension Plan Investment Board transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 64,000 shares of CLDX stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,000
Holding current value
$1.65 Million
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.06 - $44.56 $2.05 Million - $2.85 Million
64,000 New
64,000 $2.17 Million
Q1 2022

May 13, 2022

SELL
$27.64 - $39.32 $652,304 - $927,952
-23,600 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$35.68 - $56.27 $449,568 - $709,002
12,600 Added 114.55%
23,600 $912,000
Q3 2021

Nov 15, 2021

BUY
$28.95 - $55.99 $318,450 - $615,890
11,000 New
11,000 $594,000

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.21B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.